Tower Research Capital LLC (TRC) - CONTEXT THERAPEUTICS INC ownership

CONTEXT THERAPEUTICS INC's ticker is and the CUSIP is 21077P108. A total of 25 filers reported holding CONTEXT THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CONTEXT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,534
+42.5%
8,963
+51.0%
0.00%
Q2 2023$9,499
+189880.0%
5,937
-32.9%
0.00%
Q1 2023$5
-16.7%
8,843
-0.2%
0.00%
Q4 2022$6
-99.9%
8,857
+21.3%
0.00%
Q3 2022$8,000
+33.3%
7,299
+145.9%
0.00%
Q2 2022$6,0002,968
+8893.9%
0.00%
Q1 2022$0
-100.0%
33
-98.4%
0.00%
Q4 2021$6,0002,0540.00%
Other shareholders
CONTEXT THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,143,745$745,3790.25%
Affinity Asset Advisors, LLC 883,654$583,6530.23%
swisspartners Ltd. 180,000$118,8960.15%
Worth Venture Partners, LLC 281,889$186,1880.11%
DIFESA CAPITAL MANAGEMENT, LP 34,878$22,7300.02%
Aspire Wealth Management Corp 10,000$6,5170.01%
Virtu Financial LLC 57,455$380.01%
Mill Creek Capital Advisors, LLC 104,631$68,1880.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 105,809$69,8870.00%
GEODE CAPITAL MANAGEMENT, LLC 61,202$400.00%
View complete list of CONTEXT THERAPEUTICS INC shareholders